Welcome to Seeking Alpha's Wall Street Lunch, our afternoon update on today's market action, news, and analysis.

Good afternoon. Today is Tuesday, January 21st, and I'm your host, Kim Khan. Our top story so far,

Google's Deep Mind spin-off, isomorphic labs Labs expects clinical trials of drugs designed using AI to start

late this year. That's according to Bloomberg. CEO, Demis Hesabas said at a Davos panel,

we'll hopefully have some AI-designed drugs and clinical trials by the end of the year. That's the

plan. Isomorphic is working on reducing the drug discovery process from a decade or more to weeks or months,

said Hasebis, who along with deep-mind scientist John Jumper, shared the 2024 Nobel Prize in

Chemistry with the U.S. professor for their research and forecasting protein structures.

AI's ability to process large amounts of data can potentially help speed up the drug development

process,

but most major pharmaceutical companies have taken a measured approach to using the technology.

A Bloomberg intelligence report showed that the preliminary data for clinical candidates has

been mixed. Alphabet created isomorphic in 2021 to commercialize DeepMind's AI for drug discovery.

In today's trading, stocks are higher and choppy action as the second Trump administration begins. The Dow is faring better than the

S&P and the NASDAQ. In the treasury market, there is buying on the long end, with the 10-year

treasury yield falling again back below 4.6%. Clark Jaronin, chief market strategist at Calbay Investment, says,

while Tuesday is the first trading session under Trump 2.0, markets are already looking forward,

and much of the optimism over the potential for tax cuts and deregulation is already priced in

via the post-election stock market surge, which stocks have held onto for the most part.

While January has been volatile for stock so far, as of now, the S&P 500 is positive for

the month of January, he said. January's performance tends to portend, at least historically,

the market's performance for the full year. The next 10 days will be important for markets.

...